Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial

PURPOSE: In this placebo-controlled trial, we aimed to evaluate the clinical results of using PDE-5 inhibitor, tadalafil 5 mg OD, for management of CP/CPPS. PATIENTS AND METHODS: 140 patients ≤ 45 years old with moderate/severe CP/CPPS associated with ED (IIEF-5 < 22) were randomly divided and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawfik, Ahmed M., Radwan, Mohammed H., Abdulmonem, Mohammed, Abo-Elenen, Mohammed, Elgamal, Samir A., Aboufarha, Mohammed O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512753/
https://www.ncbi.nlm.nih.gov/pubmed/35802142
http://dx.doi.org/10.1007/s00345-022-04074-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512753/
https://www.ncbi.nlm.nih.gov/pubmed/35802142
http://dx.doi.org/10.1007/s00345-022-04074-4

Ejemplares similares